This Block Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday – Amcor (NYSE:AMCR), Cava Group (NYSE:CAVA)

Jul 2, 2025
this-block-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-wednesday-–-amcor-(nyse:amcr),-cava-group-(nyse:cava)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc analyst Christopher Carril initiated coverage on CAVA Group, Inc. CAVA with an Overweight rating and announced a price target of $100. Cava Group shares closed at $82.32 on Tuesday. See how other analysts view this stock.
  • HC Wainwright & Co. analyst Brandon Folkes initiated coverage on Zevra Therapeutics, Inc. ZVRA with a Buy rating and announced a price target of $26. Zevra Therapeutics shares closed at $8.95 on Tuesday. See how other analysts view this stock.
  • Compass Point analyst Dominick Gabriele initiated coverage on Block, Inc. XYZ with a Buy rating and announced a price target of $80. Block shares closed at $68.27 on Tuesday. See how other analysts view this stock.
  • Jefferies analyst Philip Ng initiated coverage on Amcor plc AMCR with a Buy rating and announced a price target of $12. Amcor shares closed at $9.47 on Tuesday. See how other analysts view this stock.
  • Barclays analyst Andrew Mok initiated coverage on Oscar Health, Inc. OSCR with an Underweight rating and announced a price target of $17. Oscar Health shares closed at $20.45 on Tuesday. See how other analysts view this stock.

Considering buying XYZ stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Loading…

Loading…

AMCR Logo

AMCRAmcor PLC

$9.641.80%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Edge Rankings

Momentum

35.39

Growth

27.91

Quality

36.07

Value

33.45

Price Trend

Short

Medium

Long

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment